Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer

Gynecologic Oncology

Volumn 125, Issue 1, 2012, Pages 99-102

  Long, Kara C ^a   Zhou, Qin ^a   Hensley, Martee L ^a   Alektiar, Kaled M ^a   Gomez, Jacob ^a   Gardner, Ginger J ^a   Chi, Dennis S ^a   Barakat, Richard R ^a   Abu Rustum, Nadeem R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

1988 FIGO stage IC endometrioid endometrial adenocarcinoma; Patterns of recurrence; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858339795     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.11.020     Document Type: Article

References (18)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. N.R. Abu-Rustum, Q. Zhou, J.D. Gomez, K.M. Alektiar, M.L. Hensley, and R.A. Soslow A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care Gynecol Oncol 116 2010 399 403
3. R.C. Boronow, C.P. Morrow, W.T. Creasman, P.J. Disaia, S.G. Silverberg, and A. Miller Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832 (Pubitemid 14105231)
4. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 8 Suppl. 1987 2035 2041 (Pubitemid 17145924)
5. D.M. Larson, G.P. Connor, S.K. Broste, B.R. Krawisz, and K.K. Johnson Prognostic significance of gross myometrial invasion with endometrial cancer Obstet Gynecol 88 1996 394 398 (Pubitemid 26293285)
6. C.L. Creutzberg, W.L. van Putten, C.C. Wárlám-Rodenhuis, A.C. van den Bergh, K.A. de Winter, and P.C. Koper Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial J Clin Oncol 22 2004 1234 1241 (Pubitemid 41079837)
7. T. Fujimoto, H. Nanjyo, J. Fukuda, A. Nakamura, H. Mizunuma, and N. Yaegashi Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence Gynecol Oncol 112 2009 342 347
8. P.W. Grigsby, C.A. Perez, A. Kuten, J.R. Simpson, D.M. Garcia, and H.M. Camel Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system Int J Radiat Oncol Biol Phys 22 1992 905 911
9. N.R. Abu-Rustum, Q. Zhou, A. Iasonos, K.M. Alektiar, M.M. Leitao, and D.S. Chi The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer 21 2011 511 516
10. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751 (Pubitemid 38251372)
11. J.M. Satagopan, L. Ben-Porat, M. Berwick, M. Robson, D. Kutler, and A.D. Auerbach A note on competing risks in survival data analysis Br J Cancer 91 2004 1229 1235 (Pubitemid 39424779)
12. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
13. J. Fine, and R. Gray A proportional hazards model for subdistribution of competing risk JASA 1999 496 509
14. J.H. Meerwaldt, C.J. Hoekstra, W.L. van Putten, A.J. Tjokrowardojo, and P.C. Koper Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors Int J Radiat Oncol Biol Phys 18 1990 299 304 (Pubitemid 20097523)
15. R.A. Nout, V.T. Smit, H. Putter, I.M. Jürgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
16. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Wárlám-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomized trial-PORTEC study group, Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411 (Pubitemid 30215963)
17. N. Rasool, A.N. Fader, L. Seamon, N.L. Neubauer, F.A. Shahin, and H.A. Alexander Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence Gynecol Oncol 116 2010 10 14
18. J. Aalders, V. Abeler, P. Kolstad, and M. Onsrud Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients Obstet Gynecol 56 1980 419 427 (Pubitemid 10018299)